PubMed: <em>Cannabis sativa</em>: origin and history, glandular trichome development, and cannabinoid biosynthesis

PubMed: <em>Cannabis sativa</em>: origin and history, glandular trichome development, and cannabinoid biosynthesis

Hortic Res. 2023 Jul 26;10(9):uhad150. doi: 10.1093/hr/uhad150. eCollection 2023 Sep.

ABSTRACT

Is Cannabis a boon or bane? Cannabis sativa has long been a versatile crop for fiber extraction (industrial hemp), traditional Chinese medicine (hemp seeds), and recreational drugs (marijuana). Cannabis faced global prohibition in the twentieth century because of the psychoactive properties of ∆9-tetrahydrocannabinol; however, recently, the perspective has changed with the recognition of additional therapeutic values, particularly the pharmacological potential of cannabidiol. A comprehensive understanding of the underlying mechanism of cannabinoid biosynthesis is necessary to cultivate and promote globally the medicinal application of Cannabis resources. Here, we comprehensively review the historical usage of Cannabis, biosynthesis of trichome-specific cannabinoids, regulatory network of trichome development, and synthetic biology of cannabinoids. This review provides valuable insights into the efficient biosynthesis and green production of cannabinoids, and the development and utilization of novel Cannabis varieties.

PMID:37691962 | PMC:PMC10485653 | DOI:10.1093/hr/uhad150

https://pubmed.ncbi.nlm.nih.gov/37691962/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1NqsX9BbHlDygQ8TcgAlJilHgPpiuKQtyIr–a3-xbLzPoB9xM&fc=20220928170152&ff=20230911190700&v=2.17.9.post6+86293ac September 11, 2023 10:00 am